Amgen to sell cholesterol drug at 60% discount direct to US consumers
1. Amgen launched discounted direct-to-consumer sales of Repatha, addressing drug price concerns.
FAQ
Why Bullish?
Demand for Repatha may increase due to direct consumer access, similar to past successful launches in pharmaceuticals. Historically, direct-to-consumer strategies have enhanced sales and market share for drug companies.
How important is it?
The launch addresses significant consumer needs and political pressures for lower drug prices, potentially improving Amgen’s market position and revenue.
Why Short Term?
Immediate market response expected as consumers are likely to capitalize on price reduction. Short-term sales growth could drive stock performance, as seen in previous direct-to-consumer launches.